I would seriously question the economic viability of producing anti parasitic medications. Pharmas don't waste time on boards like this, they strike at manipulating peer reviewed data. Furthermore they focus on wide scope products such as Statins, chemo drugs and the like where there is a profitable market for such. Any basic business course would teach this.